View in EDS

An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.

Saved in:
Bibliographic Details
Title: An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.
Authors: Wang JH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia., Chuang YF; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Chen J; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Singh V; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Lin FL; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Wilson R; Central Science Laboratory, University of Tasmania, Hobart, Tasmania, Australia., Tu L; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Ma C; Molecular Diagnostics Solutions, CSIRO Health and Biosecurity, North Ryde, New South Wales, Australia., Wong RCB; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia., Wang PY; Oujiang Laboratory, Wenzhou, Zhejiang, China., Zhong J; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Hewitt AW; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., van Wijngaarden P; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia., Dusting GJ; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia., Liu GS; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.; Aier Eye Institute, Changsha, Hunan, China.
Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2022 Aug; Vol. 32 (4), pp. 251-266. Date of Electronic Publication: 2022 Mar 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-3345 (Electronic) Linking ISSN: 21593337 NLM ISO Abbreviation: Nucleic Acid Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35363088
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+JH%22">Wang JH</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Chuang+YF%22">Chuang YF</searchLink>; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Singh+V%22">Singh V</searchLink>; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.<br /><searchLink fieldCode="AU" term="%22Lin+FL%22">Lin FL</searchLink>; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.<br /><searchLink fieldCode="AU" term="%22Wilson+R%22">Wilson R</searchLink>; Central Science Laboratory, University of Tasmania, Hobart, Tasmania, Australia.<br /><searchLink fieldCode="AU" term="%22Tu+L%22">Tu L</searchLink>; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Ma+C%22">Ma C</searchLink>; Molecular Diagnostics Solutions, CSIRO Health and Biosecurity, North Ryde, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wong+RCB%22">Wong RCB</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+PY%22">Wang PY</searchLink>; Oujiang Laboratory, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Zhong+J%22">Zhong J</searchLink>; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Hewitt+AW%22">Hewitt AW</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.<br /><searchLink fieldCode="AU" term="%22van+Wijngaarden+P%22">van Wijngaarden P</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Dusting+GJ%22">Dusting GJ</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+GS%22">Liu GS</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.; Aier Eye Institute, Changsha, Hunan, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101562758%22">Nucleic acid therapeutics</searchLink> [Nucleic Acid Ther] 2022 Aug; Vol. 32 (4), pp. 251-266. <i>Date of Electronic Publication: </i>2022 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%2C+Inc%22">Mary Ann Liebert, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101562758 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-3345 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221593337%22">21593337 </searchLink><i>NLM ISO Abbreviation: </i>Nucleic Acid Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35363088
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1089/nat.2021.0111
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 251
    Titles:
      – TitleFull: An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang JH
      – PersonEntity:
          Name:
            NameFull: Chuang YF
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Singh V
      – PersonEntity:
          Name:
            NameFull: Lin FL
      – PersonEntity:
          Name:
            NameFull: Wilson R
      – PersonEntity:
          Name:
            NameFull: Tu L
      – PersonEntity:
          Name:
            NameFull: Ma C
      – PersonEntity:
          Name:
            NameFull: Wong RCB
      – PersonEntity:
          Name:
            NameFull: Wang PY
      – PersonEntity:
          Name:
            NameFull: Zhong J
      – PersonEntity:
          Name:
            NameFull: Hewitt AW
      – PersonEntity:
          Name:
            NameFull: van Wijngaarden P
      – PersonEntity:
          Name:
            NameFull: Dusting GJ
      – PersonEntity:
          Name:
            NameFull: Liu GS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2159-3345
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Nucleic acid therapeutics
              Type: main
ResultId 1